Khalil Chaïbi

Critical care — Hôpital Avicenne, France

LeadR Profile

Khalil Chaïbi Hôpital Avicenne France
260 ScienceLeadR Reputation 260
Network Map

Critical care

Subspecialties: Nephrology - Pulmonology - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2016 - 2026

Source: PubMed

Hôpital Avicenne

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The UNDERSCORE for RRT weaning prediction: promising but not yet ready to unplug. Author's reply.
critical care, intensive care units, weaning
Intensive Care Med20260
Predictive factors of successful renal replacement therapy weaning : Deciding On patients Orientations after Renal replacement therapy Stopping (The DOORS study).
critical care, therapeutics, intensive care units, renal replacement therapy, weaning
Intensive Care Med20260
Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial.
kidney, critical illness, peptide hydrolases, acute kidney injury, prognosis
Crit Care20260
Early biomarker detection: fundamentally disputable? Authors' Reply.
critical care, biomarkers, intensive care units
Intensive Care Med20260
Biomarkers and the prediction of acute kidney injury and renal replacement therapy initiation: a dream within a dream.
critical care, kidney, biomarkers, therapeutics, intensive care units, renal replacement therapy, dreams, acute kidney injury
Intensive Care Med20250

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 5

By status:

Completed 2
Recruiting 2
Active not recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Antimicrobial Therapy for Difficult to treat Pseudomonas Aeruginosa
NCT06738771 — pseudomonas infections, pharmaceutical preparations, drug resistance, multiple, cohort studies, pseudomonas, drug resistance, multiple, bacterial, pseudomonas aeruginosa, beta-lactams, therapeutics, anti-bacterial agents, prognosis, infections, lactams, drug resistance
N/ARecruiting2025
IHD Versus CRRT for Severe Acute Kidney Injury in Critically Ill Patients
NCT06032884 — continuous renal replacement therapy, kidney, critical illness, therapeutics, intensive care units, renal replacement therapy, wounds and injuries, acute kidney injury
N/ARecruiting2023
PupillOmetry for Prediction of DelirIUM
NCT05248035 — delirium, reflex, intensive care units, ventilation
N/AActive not recruiting2022

LeadR Networks

Main global connection map